 | Alex Sacerdote | Whale Rock Capital Management | Technology growth long/short | $12.5B | 35 | 2026Q2 |
 | Andreas Halvorsen | Viking Global Investors | Long/short equity | $35.1B | 90 | 2026Q2 |
 | Barry Rosenstein | JANA Partners | Event-driven activist | $1.9B | 10 | 2026Q2 |
 | Bill Ackman | Pershing Square Capital Management | Concentrated activist | $13.7B | 11 | 2026Q1 |
 | Bill Gates | Gates Foundation Trust | Long-term concentrated endowment | $34.4B | 24 | 2026Q2 |
 | Bill Miller | Miller Value Partners | Contrarian value | $423.1M | 56 | 2026Q2 |
 | Bill Nygren | Harris Associates (Oakmark Funds) | Value | $75.2B | 162 | 2026Q2 |
 | Brad Gerstner | Altimeter Capital | Technology growth | $9.8B | 20 | 2026Q2 |
 | Carl Icahn | Icahn Capital | Activist / value | $8.3B | 12 | 2026Q2 |
 | Cathie Wood | ARK Investment Management | Disruptive innovation | $15.4B | 190 | 2026Q2 |
 | Charlie Munger | Daily Journal Corporation | Concentrated value | $256.7M | 4 | 2026Q2 |
 | Chase Coleman | Tiger Global Management | Growth / technology | $24.0B | 46 | 2026Q2 |
 | Chris Davis | Davis Advisors (Davis Selected Advisers) | Long-term value | $23.3B | 112 | 2026Q2 |
 | Chris Hohn | TCI Fund Management | Concentrated quality / activist | $52.8B | 11 | 2026Q2 |
 | Chuck Akre | Akre Capital Management | Quality compounding | $5.1B | 20 | 2026Q2 |
 | Cliff Asness | AQR Capital Management | Systematic multi-factor | $286.8B | 3900 | 2026Q2 |
 | Dan Sundheim | D1 Capital Partners | Crossover growth (public + private) | $34.8B | 55 | 2026Q2 |
 | Daniel Loeb | Third Point | Event-driven / activist | $4.6B | 41 | 2026Q2 |
 | David Abrams | Abrams Capital Management | Concentrated value | $5.5B | 11 | 2026Q2 |
 | David Booth | Dimensional Fund Advisors | Systematic factor investing | $551.8B | 3221 | 2026Q2 |
 | David Einhorn | Greenlight Capital | Long/short value | $3.9B | 46 | 2026Q2 |
| DK | David Katz | Matrix Asset Advisors | Value equity | $1.2B | 100 | 2026Q3 |
 | David Tepper | Appaloosa Management | Opportunistic / distressed | $7.5B | 27 | 2026Q2 |
| DK | Dev Kantesaria | Valley Forge Capital Management | Concentrated quality | $3.1B | 7 | 2026Q2 |
 | Duan Yongping | H&H International Investment | Concentrated long-term value | $19.1B | 18 | 2026Q2 |
 | Francois Rochon | Giverny Capital | Quality growth (buy-and-hold) | $3.0B | 51 | 2026Q2 |
 | George Soros | Soros Fund Management LLC | Global macro | $6.1B | 250 | 2026Q2 |
 | Glen Kacher | Light Street Capital | Technology long/short equity | $850.7M | 28 | 2026Q2 |
 | Glenn Welling | Engaged Capital LLC | Small/mid-cap activist | $322.9M | 9 | 2026Q2 |
 | Henry Ellenbogen | Durable Capital Partners | Growth equity (small/mid-cap) | $10.3B | 36 | 2026Q2 |
 | Howard Marks | Oaktree Capital Management | Distressed / credit value | $3.8B | 58 | 2026Q2 |
| JS | Jeff Smith | Starboard Value LP | Activist value | $4.5B | 22 | 2026Q2 |
| JG | Joel Greenblatt | Gotham Asset Management | Systematic value (long/short) | $43.0B | 1791 | 2026Q2 |
| JP | John Paulson | Paulson & Co. Inc. | Event-driven / merger arbitrage | $2.6B | 8 | 2026Q2 |
| JT | Josh Tarasoff | Greenlea Lane Capital Management | Concentrated quality compounding | $364.2M | 10 | 2026Q2 |
| KS | Karthik Sarma | SRS Investment Management | Long/short equity | $10.7B | 33 | 2026Q2 |
| KM | Keith Meister | Corvex Management LP | Activist value | $3.2B | 25 | 2026Q2 |
| LR | Larry Robbins | Glenview Capital Management | Fundamental long/short equity | $5.0B | 45 | 2026Q2 |
 | Lee Ainslie | Maverick Capital | Long/short equity | $11.1B | 179 | 2026Q2 |
| LC | Leon Cooperman | Omega Family Office | Value-oriented long equity | $3.5B | 39 | 2026Q2 |
 | Li Lu | Himalaya Capital Management | Concentrated long-term value | $3.7B | 8 | 2026Q2 |
 | Louis Bacon | Moore Capital Management, LP | Global macro | $4.3B | 741 | 2026Q2 |
| MS | Marc Stad | Dragoneer Investment Group | Technology growth (public + private) | $2.8B | 12 | 2026Q2 |
| MH | Mason Hawkins | Southeastern Asset Management (Longleaf Partners) | Concentrated value | $1.9B | 47 | 2026Q2 |
| MM | Mason Morfit | ValueAct Capital | Constructive activist | $5.6B | 18 | 2026Q2 |
| MP | Mohnish Pabrai | Pabrai Investment Funds | Concentrated value | $326.7M | 4 | 2026Q2 |
| NP | Nelson Peltz | Trian Fund Management, L.P. | Activist value | $4.2B | 8 | 2026Q2 |
 | Paul Singer | Elliott Investment Management L.P. | Multi-strategy activist | $14.3B | 29 | 2026Q2 |
 | Paul Tudor Jones | Tudor Investment Corporation | Global macro | $24.2B | 3457 | 2026Q2 |
 | Philippe Laffont | Coatue Management | Technology growth | $48.6B | 66 | 2026Q2 |
 | Prem Watsa | Fairfax Financial Holdings | Insurance-float value investing | $2.6B | 32 | 2026Q2 |
 | Ray Dalio (founder) | Bridgewater Associates | Global macro | $24.4B | 997 | 2026Q2 |
 | Renaissance Technologies | Renaissance Technologies | Quantitative | $72.6B | 3140 | 2026Q2 |
| RC | Rob Citrone | Discovery Capital Management | Global macro | $2.4B | 113 | 2026Q2 |
| RV | Robert Vinall | RV Capital | Concentrated quality (long-term) | $382.9M | 13 | 2026Q2 |
| SF | Scott Ferguson | Sachem Head Capital Management LP | Concentrated activist value | $4.8B | 19 | 2026Q2 |
 | Stephen Mandel | Lone Pine Capital | Growth / long-short | $16.4B | 34 | 2026Q2 |
 | Steve Cohen | Point72 Asset Management, L.P. | Multi-strategy | $62.9B | 3858 | 2026Q2 |
 | Terry Smith | Fundsmith LLP | Quality growth | $13.6B | 41 | 2026Q2 |
| TR | Thomas Russo | Gardner Russo & Quinn | Global quality compounders | $8.9B | 85 | 2026Q2 |
| TG | Tom Gayner | Markel Group | Insurance-float equity compounding | $13.1B | 130 | 2026Q2 |
| WW | Wallace Weitz | Weitz Investment Management | Value | $1.4B | 50 | 2026Q2 |
 | Warren Buffett | Berkshire Hathaway | Concentrated long-term value | $299.3B | 29 | 2026Q2 |
